S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
NASDAQ:MMSI

Merit Medical Systems Stock Forecast, Price & News

$55.72
-0.64 (-1.14 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$55.28
Now: $55.72
$56.53
50-Day Range
$53.23
MA: $55.51
$58.11
52-Week Range
$25.18
Now: $55.72
$58.70
Volume296,678 shs
Average Volume320,937 shs
Market Capitalization$3.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.21
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, interventional fluid management, pressure monitoring, and cardiac rhythm management, as well as thermodilution and pulmonary artery catheters and electrophysiology to treat various heart conditions. It also offers cardiovascular and critical care products to treat patients with life-threatening diseases, and protect healthcare providers from exposure to bloodborne pathogens. In addition, it provides interventional oncology and spine products to treat vertebral compression fractures, metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, it offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; microelectromechanical system sensor components; ConvertX nephroureteral stent system; and Fibrovein, a detergent-based sclerosant. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was founded in 1987 and is headquartered in South Jordan, Utah.
Merit Medical Systems logo

MarketRank

Overall MarketRank

1.94 out of 5 stars

Medical Sector

60th out of 1,558 stocks

Surgical & Medical Instruments Industry

12th out of 137 stocks

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:MMSI
CUSIP58988910
Phone801-253-1600
Employees6,355

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$994.85 million
Cash Flow$3.35 per share
Book Value$17.21 per share

Profitability

Net Income$5.45 million

Miscellaneous

Market Cap$3.10 billion
Next Earnings Date2/22/2021 (Estimated)
OptionableOptionable
$55.72
-0.64 (-1.14 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

How has Merit Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MMSI shares have increased by 69.5% and is now trading at $55.72.
View which stocks have been most impacted by COVID-19
.

Is Merit Medical Systems a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Merit Medical Systems?

Wall Street analysts have given Merit Medical Systems a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Merit Medical Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021.
View our earnings forecast for Merit Medical Systems
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) released its quarterly earnings data on Wednesday, October, 28th. The medical instruments supplier reported $0.42 EPS for the quarter, beating the consensus estimate of $0.19 by $0.23. The medical instruments supplier had revenue of $243.98 million for the quarter, compared to analyst estimates of $219.05 million. Merit Medical Systems had a negative net margin of 3.05% and a positive return on equity of 9.02%.
View Merit Medical Systems' earnings history
.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems updated its fourth quarter earnings guidance on Wednesday, October, 28th. The company provided earnings per share (EPS) guidance of $0.41-0.46 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.41. The company issued revenue guidance of $244-253 million, compared to the consensus revenue estimate of $259.27 million.

What price target have analysts set for MMSI?

8 equities research analysts have issued twelve-month target prices for Merit Medical Systems' stock. Their forecasts range from $55.00 to $72.00. On average, they expect Merit Medical Systems' share price to reach $61.75 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for Merit Medical Systems
or view Wall Street analyst' top-rated stocks.

Who are some of Merit Medical Systems' key competitors?

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:
  • Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 71, Pay $2.04M)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer (Age 42, Pay $601.64k)
  • Mr. Ronald A. Frost, Chief Operating Officer (Age 59, Pay $663.59k)
  • Mr. Justin J. Lampropoulos, Pres of EMEA (Age 38, Pay $644.47k)
  • Mr. Joseph C. Wright, Pres of International Division (Age 51, Pay $898.63k)
  • Mr. Jason Treft, Chief Technology Officer
  • Mr. Joseph Pierce, Chief Information Officer
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 60)
  • Ms. Anne-Marie Wright, VP of Corp. Communications
  • Mr. Mike Voigt, Chief HR Officer

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.07%) and Crossmark Global Holdings Inc. (0.02%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, David Floyd, David Ming-Teh Liu, Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems
.

Which institutional investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, David Ming-Teh Liu, Franklin J Miller, Fred P Lampropoulos, and Nolan E Karras.
View insider buying and selling activity for Merit Medical Systems
or view top insider-selling stocks.

Which institutional investors are buying Merit Medical Systems stock?

MMSI stock was purchased by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc.. Company insiders that have bought Merit Medical Systems stock in the last two years include David Floyd, Enterprise Associates 14 New, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems
or or view top insider-buying stocks.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $55.72.

How big of a company is Merit Medical Systems?

Merit Medical Systems has a market capitalization of $3.10 billion and generates $994.85 million in revenue each year. The medical instruments supplier earns $5.45 million in net income (profit) each year or $1.46 on an earnings per share basis. Merit Medical Systems employs 6,355 workers across the globe.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is www.merit.com.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.